BIOHARVEST SCIENCES INC(BHST),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BHST BIOHARVEST SCIENCES INC

Pre-Mkt 12-16 08:29:02 EST

5.20

-0.10

-1.89%

High5.38	Low5.10	Vol49.28K
Open5.34	D1 Closing5.30	Amplitude5.28%
Mkt Cap117.80M	Tradable Cap92.64M	Total Shares22.65M
T/O256.17K	T/O Rate0.28%	Tradable Shares17.82M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BHST","market":"US","secType":"STK","nameCN":"BIOHARVEST SCIENCES INC","latestPrice":5.2,"timestamp":1765832400000,"preClose":5.3,"halted":0,"volume":49277,"delay":0,"floatShares":17815400,"shares":22654300,"eps":-0.683165,"marketStatus":"Pre-Mkt","change":-0.1,"latestTime":"12-16 08:29:02 EST","open":5.34,"high":5.38,"low":5.1,"amount":256174.8585,"amplitude":0.05283,"askPrice":6.46,"askSize":100,"bidPrice":4.64,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.683165,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765895400000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":5.2,"postHourTrading":{"tag":"盘后","latestPrice":5.2,"preClose":5.2,"latestTime":"16:10 EST","volume":5,"amount":26,"timestamp":1765833004969},"volumeRatio":0.5486292334882059},"requestUrl":"/m/hq/s/BHST/tweets","defaultTab":"tweets","newsList":[{"id":"2586407268","title":"Analysts Offer Insights on Consumer Goods Companies: BioHarvest Sciences (BHST) and JM Smucker (SJM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2586407268","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586407268?lang=en_us&edition=fundamental","pubTime":"2025-11-26 07:30","pubTimestamp":1764113443,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on BioHarvest Sciences (BHST – Research Report) and...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-consumer-goods-companies-bioharvest-sciences-bhst-and-jm-smucker-sjm-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-consumer-goods-companies-bioharvest-sciences-bhst-and-jm-smucker-sjm-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","SJM","BK4585","BK4212","BHST","BK4183"],"gpt_icon":0},{"id":"2583221511","title":"BioHarvest Sciences Inc. - Common Stock Q3 EPS $(0.14) Misses $(0.12) Estimate, Sales $9.067M Miss $9.123M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2583221511","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583221511?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:04","pubTimestamp":1763067868,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc. - Common Stock (NASDAQ:BHST) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.12) by 16.67 percent. This is a 12.5 percent increase over losses of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48849801/bioharvest-sciences-inc-common-stock-q3-eps-0-14-misses-0-12-estimate-sales-9-067m-miss-9-123m-esti","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BioHarvest Sciences Inc. - Common Stock Q3 EPS $(0.14) Misses $(0.12) Estimate, Sales $9.067M Miss $9.123M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BHST"],"gpt_icon":0},{"id":"2583551148","title":"BioHarvest Sciences Inc. reports Q3 revenue of $9.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583551148","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583551148?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:03","pubTimestamp":1763067798,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc. reported unaudited financial results for the three and nine months ended September 30, 2025. Revenues for the third quarter of 2025 were $9.1 million, up from $6.5 million in the same period of 2024. For the nine-month period, revenues reached $25.4 million compared to $17.9 million in 2024. Gross profit for the nine months was $15.3 million, up from $9.8 million in the prior year. Total operating expenses for the nine-month period were $19.7 million, compared to $15.1 million in 2024. The company reported a net loss of $8.9 million for the nine months ended September 30, 2025. BioHarvest Sciences Inc. has an accumulated deficit of $105.3 million as of September 30, 2025, and continues to rely on fundraising to finance its activities, raising substantial doubt about its ability to continue as a going concern.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDLc1tw11:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BHST"],"gpt_icon":0},{"id":"2582374145","title":"BioHarvest Sciences Inc. to Attend Craig-Hallum Alpha Select Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2582374145","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582374145?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:42","pubTimestamp":1762954969,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc. will attend the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025, at the Sheraton New York Times Square Hotel. CEO Ilan Sobel will hold one-on-one meetings with institutional investors, highlighting the company's momentum in its consumer and CDMO divisions, robust performance of its VINIA capsule business, new product lines like VINIA Daily Chews 2X Formula and VINIA Blood Flow Hydration Solution, and advancements in plant-based exosome production and saffron compound development.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioharvest Sciences Inc. published the original content used to generate this news brief via Newsfile  on November 12, 2025, and is solely responsible for the informa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDLbpL69F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BHST"],"gpt_icon":0},{"id":"2582367397","title":"Analysts Offer Insights on Consumer Goods Companies: BioHarvest Sciences (BHST) and HF Foods Group (HFFG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2582367397","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582367397?lang=en_us&edition=fundamental","pubTime":"2025-11-12 04:50","pubTimestamp":1762894226,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on BioHarvest Sciences (BHST – Research Report) and...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-consumer-goods-companies-bioharvest-sciences-bhst-and-hf-foods-group-hffg-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-consumer-goods-companies-bioharvest-sciences-bhst-and-hf-foods-group-hffg-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4183","BK4102","HF","BHST","HFFG"],"gpt_icon":0},{"id":"2580800739","title":"Bioharvest Sciences Inc. to Release Third Quarter 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2580800739","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580800739?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:31","pubTimestamp":1762259497,"startTime":"0","endTime":"0","summary":"Bioharvest Sciences Inc. will release its third quarter 2025 financial results after market close on Thursday, November 13, 2025. Management will host an investor conference call and webcast to discuss the results at 4:30 p.m. Eastern time on the same day. The webcast can be accessed at BHST Q3 2025 Earnings Conference Call.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioharvest Sciences Inc. published the original content used to generate this news brief via Newsfile  on November 04, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nNDL3Fswng:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST","BK4183"],"gpt_icon":0},{"id":"2580416698","title":"BioHarvest Sciences and Saffron Tech Partner to Develop Saffron-Derived Compounds","url":"https://stock-news.laohu8.com/highlight/detail?id=2580416698","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580416698?lang=en_us&edition=fundamental","pubTime":"2025-11-01 04:25","pubTimestamp":1761942341,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc. has announced a strategic CDMO  agreement with Saffron Tech Ltd., a company specializing in advanced saffron cultivation methods. The collaboration aims to develop and commercialize saffron-derived botanical compounds using BioHarvest's patented Botanical Synthesis platform, which allows for scalable and consistent production of plant-based molecules without traditional plant cultivation. Under the terms of the agreement, Saffron Tech will own 75% and BioHarvest 25% of the developed saffron compositions and associated intellectual property rights. Following development, BioHarvest plans to manufacture the compounds at scale and introduce a new line of saffron-based nutraceutical products targeting cognitive function, eye health, and antioxidant benefits.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informati","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nNDL5F6KXR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST","BK4183"],"gpt_icon":0},{"id":"2580449449","title":"BioHarvest Sciences Guides Q4 2025 Revenue at $9–$9.5 Million with Adjusted EBITDA Near Breakeven","url":"https://stock-news.laohu8.com/highlight/detail?id=2580449449","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580449449?lang=en_us&edition=fundamental","pubTime":"2025-11-01 00:58","pubTimestamp":1761929932,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc. has released its preliminary unaudited financial guidance for the third and fourth quarters of 2025. For the third quarter, the company expects revenue of approximately $9.1 million, in line with management's previous guidance, and an adjusted EBITDA in the range of negative $0.7 million to negative $0.4 million. Cash and cash equivalents as of September 30, 2025, totaled around $11 million. For the fourth quarter, BioHarvest projects revenue between $9 million and $9.5 million, with adjusted EBITDA anticipated to range from negative $0.6 million to breakeven. The company notes growth in its VINIA business and CDMO Services, supported by new product launches and marketing initiatives set to roll out in the fourth quarter. Management indicates that BioHarvest is well positioned to reach adjusted EBITDA breakeven in the near term.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nNDL5scG5W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST","BK4183"],"gpt_icon":0},{"id":"2579237161","title":"BioHarvest Sciences (BHST) Gets a Buy from Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2579237161","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579237161?lang=en_us&edition=fundamental","pubTime":"2025-10-30 22:06","pubTimestamp":1761833167,"startTime":"0","endTime":"0","summary":"Craig-Hallum analyst Matt Hewitt maintained a Buy rating on BioHarvest Sciences today. The company’s shares opened today at $9.52. Hewitt covers th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bioharvest-sciences-bhst-gets-a-buy-from-craig-hallum-blurbs-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bioharvest-sciences-bhst-gets-a-buy-from-craig-hallum-blurbs-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4183","BHST"],"gpt_icon":0},{"id":"2569785429","title":"Bioharvest Sciences Inc. Reduces Debt by $3.8 Million and Secures $10.9 Million in Cash Proceeds to Strengthen Balance Sheet","url":"https://stock-news.laohu8.com/highlight/detail?id=2569785429","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569785429?lang=en_us&edition=fundamental","pubTime":"2025-09-22 18:32","pubTimestamp":1758537159,"startTime":"0","endTime":"0","summary":"Bioharvest Sciences Inc., a biotechnology company, has announced a significant strengthening of its balance sheet through a series of financial transactions. The company successfully raised $10.9 million in gross proceeds and reduced its total debt by $3.8 million. This was achieved by the exercising of 898,277 warrants and the conversion of $6.9 million of convertible notes into equity, alongside the issuance of new convertible notes worth $5.1 million which were also converted into common shares. Additionally, $1.8 million of pre-existing convertible notes were converted, and $1.4 million of long-term debt was repaid through the exercising of warrants. The company now holds approximately $6.6 million in total debt, with $3.6 million in short-term debt and $3 million in long-term debt. The proceeds will be used for capital expenditures, debt refinancing, and general working capital, supporting Bioharvest's growth initiatives. CEO Ilan Sobel highlighted the transactions as pivotal in p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250922:nNDL8W3S8C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST","BK4183"],"gpt_icon":0},{"id":"2566982663","title":"BioHarvest Sciences Unveils Pre-Close Briefing on Financial Results Ahead of September 10, 2025 Investor Webinar","url":"https://stock-news.laohu8.com/highlight/detail?id=2566982663","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566982663?lang=en_us&edition=fundamental","pubTime":"2025-09-11 04:26","pubTimestamp":1757535972,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc. has announced a pre-close brief ahead of its upcoming conference call to discuss the company's earnings and financial results. The call, hosted by CEO Ilan Sobel, is scheduled for September 10, 2025, at 1:00 p.m. ET. During the event, Sobel will provide updates on BioHarvest's recent breakthroughs, including its advancements in botanical synthesis capabilities and plant-based exosome production. The conference will conclude with a question-and-answer session for participants.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioharvest Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securitie","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nNDLc5V4gF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST","BK4183"],"gpt_icon":0},{"id":"2566689608","title":"Bioharvest Sciences Inc. Expands Capabilities with Breakthrough in Plant-Based Exosome Production at Scale","url":"https://stock-news.laohu8.com/highlight/detail?id=2566689608","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566689608?lang=en_us&edition=fundamental","pubTime":"2025-09-10 19:01","pubTimestamp":1757502085,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc. has announced a significant expansion in its capabilities with the successful large-scale production of plant-based exosomes using its proprietary Botanical Synthesis technology. This advancement marks a potential new revenue stream for the company, as it plans to explore opportunities in the health and cosmetic industries. CEO Ilan Sobel highlighted the efficiency of their bioreactors in producing high-value exosomes, which are expected to offer a safer, non-animal-derived alternative to existing options. With the global exosome market projected to grow significantly, BioHarvest's innovation positions it to capitalize on this expanding demand, particularly with plans to introduce a new skincare application within the next 18 to 24 months.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nNDLb11DJy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST","BK4183"],"gpt_icon":0},{"id":"2566391695","title":"Bioharvest Sciences Inc. Files Shelf Registration Statement to Potentially Offer Up to $100 Million in Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2566391695","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566391695?lang=en_us&edition=fundamental","pubTime":"2025-09-09 18:01","pubTimestamp":1757412076,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc., listed on NASDAQ under the ticker BHST, has announced the effectiveness of a shelf registration statement on Form F-3 with the U.S. Securities and Exchange Commission. This registration allows the company to offer and sell up to $100 million of its common shares, warrants, and units, subject to market conditions and the company's capital needs. The terms and pricing of any offerings will be detailed in a prospectus supplement at the time of the offering. The company emphasizes that this registration does not obligate them to sell any securities, and any offerings will be at their discretion based on market conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioharvest Sciences Inc. published the origina","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nNDL4h9t8h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST","BK4183"],"gpt_icon":0},{"id":"2562301051","title":"BRIEF-Bioharvest Sciences Files For Mixed Shelf Of Up To $100 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2562301051","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562301051?lang=en_us&edition=fundamental","pubTime":"2025-08-28 23:21","pubTimestamp":1756394502,"startTime":"0","endTime":"0","summary":"BRIEF-Bioharvest Sciences Files For Mixed Shelf Of Up To $100 MlnAug 28 (Reuters) - Bioharvest Sciences Inc BHST.O:BIOHARVEST SCIENCES INC FILES FOR MIXED SHELF OF UP TO $100 MILLION - SEC FILINGFurther company coverage: BHST.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nFWN3UK0WZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST","BK4183"],"gpt_icon":0},{"id":"2562051365","title":"Bioharvest Sciences Inc Files for Mixed Shelf of up to $100 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2562051365","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562051365?lang=en_us&edition=fundamental","pubTime":"2025-08-28 23:20","pubTimestamp":1756394427,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nFWN3UK0WZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","BHST"],"gpt_icon":0},{"id":"2559252896","title":"Bioharvest Sciences Inc reports results for the quarter ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2559252896","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559252896?lang=en_us&edition=fundamental","pubTime":"2025-08-13 01:45","pubTimestamp":1755020709,"startTime":"0","endTime":"0","summary":"Bioharvest Sciences Inc reports results for the quarter ended June 30 - Earnings SummaryBioharvest Sciences Inc 8MV0.MU reported a quarterly adjusted loss of 24 cents per share for the quarter ended J","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nL8N3U41LV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST"],"gpt_icon":0},{"id":"2558165273","title":"BioHarvest Sciences Inc. - Common Stock Q2 EPS $(0.24) Misses $(0.06) Estimate, Sales $8.515M Miss $13.785M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2558165273","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558165273?lang=en_us&edition=fundamental","pubTime":"2025-08-11 19:34","pubTimestamp":1754912060,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc. - Common Stock (NASDAQ:BHST) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.06) by 300 percent. This is a 500 percent decrease over losses of","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47027345/bioharvest-sciences-inc-common-stock-q2-eps-0-24-misses-0-06-estimate-sales-8-515m-miss-13-785m-est","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST"],"gpt_icon":0},{"id":"2558365911","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2558365911","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558365911?lang=en_us&edition=fundamental","pubTime":"2025-08-11 18:00","pubTimestamp":1754906400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·AMC Ent Hldgs                                    2Q      (.07)  4:15 PM. ·Barrick Mining Corp                                2Q       .46   6:00 AM. ·Gaia Inc. Class A                               2Q      (.08)  4:05 PM. ·Green Plains Inc.                               2Q      (.33)  6:55 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLDP","RPAY","LAR","ARCT","BW","PNNT","CE","CAE","PFLT","BHST","LPSN","FNV","CAVA","DDD","DEC","MRCY","HPK","RNA","IHRT","RAL","ADCT","AIOT","ACXP","BTAI","BITF","GRDN","DSP","TLS","EDRY","BTM","ALXO","CAI","GAIA","RUM","CAH","ARIS","AVXL","ARQ","BKV","COYA","INR","MRVI","CEVA","EE","ASRT","MNDY","PAL","GRWG","NGS"],"gpt_icon":1},{"id":"2557457308","title":"Bioharvest Sciences Inc  expected to post a loss of 11 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2557457308","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557457308?lang=en_us&edition=fundamental","pubTime":"2025-08-08 23:16","pubTimestamp":1754666180,"startTime":"0","endTime":"0","summary":"Bioharvest Sciences Inc <8MV0.MU> expected to post a loss of11cents a share - Earnings Preview Bioharvest Sciences Inc 8MV0.MU  is expected to  report resultson August 11 for the period ending June 30","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL8N3U02PK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST"],"gpt_icon":0},{"id":"2557316986","title":"BioHarvest Sciences Inc. Releases Pre-Close Brief Ahead of August 11, 2025, Earnings Call to Discuss Q2 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2557316986","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557316986?lang=en_us&edition=fundamental","pubTime":"2025-08-06 02:37","pubTimestamp":1754419077,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc., a leader in Botanical Synthesis technology, has announced plans to release its financial results for the second quarter ending June 30, 2025. The results will be published before market open on August 11, 2025. Following the release, the company will host a conference call and webcast at 8:00 a.m. Eastern Time on the same day to discuss the financial performance, provide a corporate update, and hold a Q&A session. Interested parties can join the call using the provided dial-in numbers or access the webcast online. A replay of the call will be available until August 25, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioharvest Sciences Inc. published the original content used to generate this news brief v","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nNDL6zctjx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bioharvest.com","stockEarnings":[{"period":"1week","weight":-0.1531},{"period":"1month","weight":-0.2808},{"period":"3month","weight":-0.4037},{"period":"6month","weight":-0.2518},{"period":"1year","weight":-0.1545},{"period":"ytd","weight":-0.1586}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.1394},{"period":"1year","weight":0.1266},{"period":"ytd","weight":0.1615}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. It engages in research and development of science based therapeutic solutions for the nutraceutical industry; and plant cell-based active pharmaceutical ingredients that can assist in the treatment of specific medical indications The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product; and medical cannabis. BioHarvest Sciences Inc. is based in Vancouver, Canada.","exchange":"NASDAQ","name":"BIOHARVEST SCIENCES INC","nameEN":"BIOHARVEST SCIENCES INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BIOHARVEST SCIENCES INC(BHST),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BIOHARVEST SCIENCES INC(BHST) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BIOHARVEST SCIENCES INC,BHST,BIOHARVEST SCIENCES INC股票,BIOHARVEST SCIENCES INC股票老虎,BIOHARVEST SCIENCES INC股票老虎国际,BIOHARVEST SCIENCES INC行情,BIOHARVEST SCIENCES INC股票行情,BIOHARVEST SCIENCES INC股价,BIOHARVEST SCIENCES INC股市,BIOHARVEST SCIENCES INC股票价格,BIOHARVEST SCIENCES INC股票交易,BIOHARVEST SCIENCES INC股票购买,BIOHARVEST SCIENCES INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BIOHARVEST SCIENCES INC(BHST),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BIOHARVEST SCIENCES INC(BHST) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction